Vedanta Biosciences

Cambridge, MA · Founded 2010 · Privately Held (backing)

Developer of orally delivered defined bacterial consortia designed to treat inflammatory and infectious diseases. Vedanta Biosciences is based in Cambridge, MA and was founded in 2010. It has raised $366 million across 4 recorded rounds; the latest was an $119 million later-stage round in Mar 2023.

Last price · $/share
—
Implied valuation
—
Total raised
$366.1M
Last round
Later Stage VC
Mar 2023

Who backs Vedanta Biosciences?

38 investors
InvestorType
Korea Investment PartnersVenture capital
Gates FoundationOther
Salica InvestmentsVenture capital
Johnson & Johnson Innovation - JLABSOther
Shinhan CapitalOther
Partners InvestmentVenture capital
Bristol-Myers Squibb—
Revelation PartnersVenture capital
Magnetar CapitalHedge fund
PEAK6 Strategic CapitalVenture capital
+ 28 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Vedanta Biosciences investors

38 investors are on record for Vedanta Biosciences, including Korea Investment Partners, Gates Foundation, Salica Investments and Johnson & Johnson Innovation - JLABS. By type, the record holds 5 hedge funds and 5 venture capital firms. The later-stage round in Mar 2023 drew 25 investors.

Free account
More of Vedanta Biosciences with a free account
  • ·The complete investor list: 38 names
  • ·Watch Vedanta Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 38 firms already write checks for companies like Vedanta Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View